Course : MOC Part IV: Non-Invasive Prenatal Screening (NIPS)

Non-invasive prenatal screening with cell free DNA has become an important part of prenatal genetics practice. This testing has been utilized to screen for the common trisomies including Trisomy 13, 18, and 21. Testing has also expanded to sex chromosomal abnormalities. More recently, some platforms have included testing for microdeletions/copy number variations. Pretest counseling is required, as well as appropriate reporting by laboratories performing the testing. Patients should be able to make adequate decisions regarding the role of NIPS in their pregnancies, as well as the potential consequences of a positive or negative result.

Registration and Fees

ACMG Members and ACMG Trainees ($25)
Non-members ($75)



  Purchase with Educational Credit

Share